Proteasome-mediated destruction of the cyclin a/cyclin-dependent kinase 2 complex suppresses tumor cell growth in vitro and in vivo

Cancer Res. 2004 Jun 1;64(11):3949-57. doi: 10.1158/0008-5472.CAN-03-3906.

Abstract

Cyclin-dependent kinases (cdks) represent potentially promising molecular targets for cancer therapeutic strategies. To evaluate the antitumor activity of selective cyclin/cdk inhibition, we constructed a chimeric protein composed of a F-box protein (TrCP) fused to a peptide comprising the cyclin/cdk2 binding motif in p21-like cdk inhibitors (TrCP-LFG). We now demonstrate that endogenous cyclin A and its binding substrate, cdk2, can be tethered to beta-TrCP, ubiquitinated, and effectively degraded. Degradation of cdk2 and cyclin A together, but not cdk2 alone, results in massive tumor cell apoptosis in vitro and in vivo in a proteasome-dependent manner with no toxicity to normal tissue. These data demonstrate that cyclin A and/or the cyclin A/cdk2 complex is a promising anticancer target with a high therapeutic index.

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Apoptosis Regulatory Proteins
  • CDC2-CDC28 Kinases / antagonists & inhibitors*
  • CDC2-CDC28 Kinases / metabolism
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Carrier Proteins / pharmacology*
  • Cell Division / drug effects
  • Cell Division / physiology
  • Cell Line, Tumor
  • Cyclin A / antagonists & inhibitors*
  • Cyclin A / metabolism
  • Cyclin-Dependent Kinase 2
  • Cysteine Endopeptidases / metabolism*
  • Female
  • Glioma / drug therapy
  • Glioma / pathology
  • HeLa Cells
  • Humans
  • Membrane Proteins
  • Mice
  • Mice, Nude
  • Multienzyme Complexes / metabolism*
  • Proteasome Endopeptidase Complex
  • Protein Engineering
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Recombinant Fusion Proteins / pharmacology
  • Transduction, Genetic
  • Xenograft Model Antitumor Assays
  • beta-Transducin Repeat-Containing Proteins / genetics
  • beta-Transducin Repeat-Containing Proteins / metabolism
  • beta-Transducin Repeat-Containing Proteins / pharmacology*

Substances

  • Apoptosis Regulatory Proteins
  • Carrier Proteins
  • Cyclin A
  • FAIM2 protein, human
  • Membrane Proteins
  • Multienzyme Complexes
  • Recombinant Fusion Proteins
  • beta-Transducin Repeat-Containing Proteins
  • CDC2-CDC28 Kinases
  • CDK2 protein, human
  • Cdk2 protein, mouse
  • Cyclin-Dependent Kinase 2
  • Cysteine Endopeptidases
  • Proteasome Endopeptidase Complex